Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03901963 |
|---|---|
| Brief Title: | A Study of Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant (AURIGA) |
| First Submitted : | April 2, 2019 |
| First Submitted that Met QC Criteria : | April 2, 2019 |
| First Posted : | April 3, 2019 |
| Last Update Submitted that Met QC Criteria : | February 5, 2020 |
| Last Update Posted : | February 6, 2020 |